Happy Father’s Day! In this week’s Innovation Partners BioBlog, we look at how the changing world of drug prices and health care laws impact pricing. U.S. drug prices fell but may rise sharply depending on future marketplace events. New markets are open now for Paxman’s scalp cooling product, and Express Script signed an agreement that ...

Our focus this week is on the pharmaceutical industry with reports from the ASCO conference shaking up stocks, improving the outlook for some while downgrading others. Many companies are announcing results, cuts, and progress with key oncology drugs this week. Check out the Innovation Partners BioBlog for the latest news. AstraZeneca hails progress with key ...

Drug costs are in the spotlight this week from many quarters. First, drugmakers called out by the Trump Administration for blocking generics are also included in a Kaiser Health study that found that they increased prices by double digits since 2012. The so-called ‘right to try’ bill passed the House and awaits President Trump’s signature, ...

Health insurance is in the news this week as insurers file their 2019 rate requests for Affordable Care Act Exchanges. The bad news: rates appear to be going up across many companies and states. The good news: The ACA appears to have helped more young women receive an earlier cancer diagnosis thanks to extended coverage ...

Major news this week as President Trump launches “American Patients First” to bring down healthcare costs. California advanced a bill to socialize healthcare prices, while Oregon looks to reinstate its own state-based insurance exchange as ACA fees and other issue force them to seek alternatives. This and more in this week’s Innovation Partners BioBlog. California ...

This week’s BioBlog looks at several interesting developments in the use of technology in the healthcare field. Three companies are looking to use a blockchain-based application to secure and encrypt provider data. Researchers have found over 850 genetic alterations may be the reason why cancer “runs in families”. CVS targets chronic kidney disease with innovative ...

This week's Innovation Partners BioBlog looks at some of the business aspects of the healthcare industry. Walmart reportedly took baby steps towards the acquisition of insurer Humana last month, while Aetna has agreed to pass drug discounts on to patients, a move hailed by many as a positive step. Discussions around cancer care models, fee ...

This week’s Innovation Partners BioBlog takes a look at the legislation moving through the government now to fund research, treatment and more. Senator Warren is proposing additional subsidies for healthcare insurance, while the new budget bill increases funding for research, drug treatment and mental healthcare. These stories and more in this week’s BioBlog. Medical Research, ...

This week’s BioBlog focuses on cancer - new drugs, advances in diagnosis and disease tracking, and improvement in healthcare and treatment access for patients. Medicare has agreed to pay for important testing to match drugs to patients with advanced cancer, and Blue Cross is launching new projects aimed at reducing disparities in healthcare due to ...

Innovation is all around us, and this week’s BioBlog from Innovation Partners examines innovation in all its forms. Two women entrepreneurs are working to develop an at-home cervical cancer screening test that will make it easier for women to test for the deadly disease, while an at-home test for breast cancer was recently approved by ...